| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5921146 | Cardiovascular Revascularization Medicine | 2015 | 4 Pages |
Abstract
The ORBIT I trial suggests that OAS treatment continues to offer a safe and effective method to change compliance of calcified coronary lesions to facilitate optimal stent placement in these difficult-to-treat patients.
Keywords
sirolimus-eluting stentMACEPCICACBMSTLROADIVUSOrbital atherectomyRotational atherectomytarget lesion revascularizationSESMyocardial infarctionDESDrug-eluting stentsZotarolimus-eluting stentBare-metal stentscoronary artery diseasemajor adverse cardiovascular eventsintravascular ultrasoundZESCADpercutaneous coronary interventionOASCoronary artery calcification
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Parloop Bhatt, Parth Parikh, Apurva Patel, Milan Chag, Anish Chandarana, Roosha Parikh, Keyur Parikh,